[EN] CDK2 INHIBITORS AND USE THEREOF<br/>[FR] INHIBITEURS DE CDK2 ET LEUR UTILISATION
申请人:QILU REGOR THERAPEUTICS INC
公开号:WO2022206888A1
公开(公告)日:2022-10-06
The present disclosure provides a compound represented by structural formula (I') or a pharmaceutically acceptable salt, or a stereoisomer thereof and their use in, e.g. treating a disease or disorder associated with CDK2. This disclosure also features compositions containing the same as well as methods of using and making the same.
本公开提供一种由结构式(I’)表示的化合物,或其药学上可接受的盐,或其立体异构体,以及它们在治疗与CDK2相关的疾病或障碍方面的用途。本公开还涉及含有相同化合物的组合物以及使用和制备相同化合物的方法。